Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Schistosoma mansoni | carbonic anhydrase II (carbonate dehydratase II) | 0.4295 | 1 | 1 |
Entamoeba histolytica | bacterial transferase hexapeptide family protein | 0.0039 | 0.0031 | 0.003 |
Loa Loa (eye worm) | eukaryotic-type carbonic anhydrase | 0.4295 | 1 | 1 |
Schistosoma mansoni | carbonic anhydrase II (carbonate dehydratase II) | 0.4295 | 1 | 1 |
Echinococcus granulosus | dynactin 5 p25 | 0.0069 | 0.0099 | 0.0099 |
Brugia malayi | Carbonic anhydrase like protein 2 precursor | 0.1622 | 0.3738 | 0.3738 |
Schistosoma mansoni | carbonic anhydrase-related | 0.1622 | 0.3738 | 0.3738 |
Trypanosoma brucei | carbonic anhydrase-like protein | 0.4295 | 1 | 1 |
Trichomonas vaginalis | conserved hypothetical protein | 0.2 | 0.4625 | 1 |
Wolbachia endosymbiont of Brugia malayi | 2,3,4,5-tetrahydropyridine-2,6-carboxylate N-succinyltransferase | 0.0069 | 0.0099 | 1 |
Brugia malayi | bHLH-PAS transcription factor | 0.0035 | 0.0021 | 0.0021 |
Leishmania major | carbonic anhydrase family protein, putative | 0.146 | 0.336 | 0.3339 |
Mycobacterium tuberculosis | Probable transmembrane carbonic anhydrase (carbonate dehydratase) (carbonic dehydratase) | 0.0577 | 0.129 | 0.3884 |
Toxoplasma gondii | hypothetical protein | 0.1622 | 0.3738 | 0.5 |
Echinococcus multilocularis | carbonic anhydrase II | 0.4295 | 1 | 1 |
Echinococcus multilocularis | atpase aaa+ type core atpase aaa type core | 0.0791 | 0.1791 | 0.1791 |
Brugia malayi | Eukaryotic-type carbonic anhydrase family protein | 0.1622 | 0.3738 | 0.3738 |
Echinococcus granulosus | carbonic anhydrase | 0.1622 | 0.3738 | 0.3738 |
Brugia malayi | Putative carbonic anhydrase 5 precursor | 0.4295 | 1 | 1 |
Echinococcus multilocularis | carbonic anhydrase | 0.1622 | 0.3738 | 0.3738 |
Brugia malayi | PAS domain containing protein | 0.0047 | 0.005 | 0.005 |
Echinococcus granulosus | Basic leucine zipper bZIP transcription | 0.0035 | 0.0021 | 0.0021 |
Brugia malayi | hypoxia-induced factor 1 | 0.0147 | 0.0282 | 0.0282 |
Mycobacterium leprae | CARBONIC ANHYDRASE (CARBONATE DEHYDRATASE) (CARBONIC DEHYDRATASE) | 0.146 | 0.336 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.1622 | 0.3738 | 0.3738 |
Schistosoma mansoni | carbonic anhydrase-related | 0.1622 | 0.3738 | 0.3738 |
Leishmania major | carbonic anhydrase-like protein | 0.4295 | 1 | 1 |
Brugia malayi | Carbonic anhydrase like protein 2 precursor | 0.1622 | 0.3738 | 0.3738 |
Mycobacterium tuberculosis | Probable serine acetyltransferase CysE (sat) | 0.0069 | 0.0099 | 0.0211 |
Trypanosoma cruzi | carbonic anhydrase-like protein, putative | 0.4295 | 1 | 1 |
Schistosoma mansoni | hypothetical protein | 0.1622 | 0.3738 | 0.3738 |
Wolbachia endosymbiont of Brugia malayi | N-acetylglucosamine-1-phosphate uridyltransferase | 0.0069 | 0.0099 | 1 |
Schistosoma mansoni | carbonic anhydrase-related | 0.1622 | 0.3738 | 0.3738 |
Loa Loa (eye worm) | hypoxia-induced factor 1 | 0.0147 | 0.0282 | 0.0282 |
Entamoeba histolytica | ankyrin, putative | 0.0069 | 0.0099 | 0.0235 |
Echinococcus granulosus | single minded 2 | 0.0035 | 0.0021 | 0.0021 |
Brugia malayi | Eukaryotic-type carbonic anhydrase family protein | 0.1622 | 0.3738 | 0.3738 |
Loa Loa (eye worm) | carbonic anhydrase 3 | 0.4295 | 1 | 1 |
Entamoeba histolytica | carbonic anhydrase, putative | 0.146 | 0.336 | 1 |
Mycobacterium ulcerans | transferase | 0.0066 | 0.0093 | 0.0157 |
Onchocerca volvulus | 0.0035 | 0.0021 | 0.2222 | |
Mycobacterium ulcerans | hypothetical protein | 0.0039 | 0.0031 | 0.0022 |
Mycobacterium ulcerans | carbonic anhydrase | 0.2 | 0.4625 | 1 |
Schistosoma mansoni | transcription factor LCR-F1 | 0.0035 | 0.0021 | 0.0021 |
Schistosoma mansoni | carbonic anhydrase | 0.1622 | 0.3738 | 0.3738 |
Loa Loa (eye worm) | hypothetical protein | 0.0159 | 0.0311 | 0.0311 |
Echinococcus granulosus | carbonic anhydrase II | 0.4295 | 1 | 1 |
Echinococcus multilocularis | transfer RNA-Lys | 0.0035 | 0.0021 | 0.0021 |
Loa Loa (eye worm) | hypothetical protein | 0.1622 | 0.3738 | 0.3738 |
Brugia malayi | hypothetical protein | 0.0159 | 0.0311 | 0.0311 |
Schistosoma mansoni | hypothetical protein | 0.0035 | 0.0021 | 0.0021 |
Mycobacterium tuberculosis | Beta-carbonic anhydrase | 0.1423 | 0.3273 | 1 |
Echinococcus granulosus | carbonic anhydrase | 0.1622 | 0.3738 | 0.3738 |
Echinococcus granulosus | carbonic anhydrase | 0.1622 | 0.3738 | 0.3738 |
Loa Loa (eye worm) | eukaryotic-type carbonic anhydrase | 0.1622 | 0.3738 | 0.3738 |
Entamoeba histolytica | acetyltransferase, putative | 0.0069 | 0.0099 | 0.0235 |
Echinococcus multilocularis | Basic leucine zipper (bZIP) transcription | 0.0035 | 0.0021 | 0.0021 |
Mycobacterium ulcerans | carbonic anhydrase | 0.146 | 0.336 | 0.7253 |
Schistosoma mansoni | carbonic anhydrase | 0.146 | 0.336 | 0.336 |
Trypanosoma cruzi | carbonic anhydrase-like protein, putative | 0.4295 | 1 | 1 |
Schistosoma mansoni | single-minded | 0.0047 | 0.005 | 0.005 |
Brugia malayi | Eukaryotic-type carbonic anhydrase family protein | 0.1622 | 0.3738 | 0.3738 |
Onchocerca volvulus | 0.0066 | 0.0093 | 1 | |
Mycobacterium tuberculosis | Beta-carbonic anhydrase CanB | 0.0883 | 0.2008 | 0.6099 |
Plasmodium falciparum | carbonic anhydrase | 0.1622 | 0.3738 | 0.5 |
Trichomonas vaginalis | conserved hypothetical protein | 0.2 | 0.4625 | 1 |
Brugia malayi | hypothetical protein | 0.0035 | 0.0021 | 0.0021 |
Echinococcus multilocularis | carbonic anhydrase | 0.1622 | 0.3738 | 0.3738 |
Schistosoma mansoni | aryl hydrocarbon receptor | 0.0047 | 0.005 | 0.005 |
Echinococcus multilocularis | carbonic anhydrase | 0.1622 | 0.3738 | 0.3738 |
Loa Loa (eye worm) | hypothetical protein | 0.2775 | 0.6441 | 0.6441 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
APD95 (functional) | = 4 % | Maximum percent change in repolarizaton at 1 uM concentration on Canine Purkinje fibers. | ChEMBL. | 2918518 |
APD95 (functional) | = 5 % | Percent change in repolarizaton at 10 Purkinje fibers.; value ranges from 3-7 | ChEMBL. | 2918518 |
APD95 (functional) | = 5 % | Maximum percent change in repolarizaton at 0.1 uM concentration on Canine Purkinje fibers. | ChEMBL. | 2918518 |
APD95 (functional) | = 15 % | Maximum percent change in repolarizaton at 30 uM concentration on Canine Purkinje fibers. | ChEMBL. | 2918518 |
CT (functional) | = -7 % | Maximum percent change in conduction time (CT) at 100 uM concentration tested on Canine ventricular muscle fibre | ChEMBL. | 2918518 |
CT (functional) | M 0 % | Percent change from control in conduction time (CT) at 10 uM concentration tested on Canine ventricular muscle fibre.; M is minimal(<10% change in CT) | ChEMBL. | 2918518 |
EC20 (functional) | NR 0 uM | Concentration of compound which gives a 20% decrease in contractile force was tested on papillary muscle of guinea pig, activity was expressed as EC-20; NR is not reached.. | ChEMBL. | 2918518 |
FRP (functional) | = 13 % | Percent change from control in the functional refractory period (FRP) at 10 microM conc. on Canine ventricular muscle fibre. | ChEMBL. | 2918518 |
FRP (functional) | = 13 % | Maximum percent change in functional refractory period (FRP) at 100 uM on Canine ventricular muscle fibre. | ChEMBL. | 2918518 |
Vmax (ADMET) | = -1 % | Maximum Percent change from control in the rate of rise of phase 0 of the action potential at 30 uM concentration on Canine Purkinje fibers. | ChEMBL. | 2918518 |
Vmax (ADMET) | = 4.6 % | Percent change from control in the rate of rise of phase 0 of the action potential at 10 uM concentration on Canine Purkinje fibers. | ChEMBL. | 2918518 |
Vmax (ADMET) | = 7 % | Maximum Percent change from control in the rate of rise of phase 0 of the action potential at 100 uM concentration on Canine Purkinje fibers. | ChEMBL. | 2918518 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
1 literature reference was collected for this gene.